Predicting response of ovarian cancer to paclitaxel treatment based on trend analysis of serum CA125

Clin Chem. 2002 Aug;48(8):1364-7.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • CA-125 Antigen / blood*
  • Female
  • Humans
  • Middle Aged
  • Neoplasm Recurrence, Local
  • Ovarian Neoplasms / diagnosis*
  • Ovarian Neoplasms / drug therapy*
  • Paclitaxel / therapeutic use*
  • Prognosis
  • Prospective Studies
  • Reference Values

Substances

  • Antineoplastic Agents, Phytogenic
  • CA-125 Antigen
  • Paclitaxel